In the published article, there was an error in the dosage of adalimumab. A correction has been made to Report, 1. This sentence previously stated:
“One month later, Adalimumab with dose of 300 mg was given subcutaneously.”
The corrected sentence appears below:
“One month later, Adalimumab with dose of 40 mg was given subcutaneously.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
Mal de Meleda, MDM, Exomiser, HPO terms, Ixekizumab, Adalimumab
Citation
Dai Y, Zheng X, Zhang Q, Hu X, Wang P and Yang S (2022) Corrigendum: Case report: Challenges in the diagnosis of a case of Mal de Meleda and a therapeutic attempt of ixekizumab and Adalimumab. Front. Med. 9:1106530. doi: 10.3389/fmed.2022.1106530
Received
23 November 2022
Accepted
30 November 2022
Published
12 December 2022
Volume
9 - 2022
Edited and reviewed by
Andreas Recke, University of Lübeck, Germany
Updates
Copyright
© 2022 Dai, Zheng, Zhang, Hu, Wang and Yang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Peiguang Wang ✉ wpg2370@163.comSen Yang ✉ yang2004sen@163.com
†These authors have contributed equally to this work
This article was submitted to Dermatology, a section of the journal Frontiers in Medicine
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.